InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001156039-23-000027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-03 2023-03-01+ ELV Kendrick Charles Morgan JR EVP, Pres, Commercial F - Tax $468.83 -1,377 14.2K -9% -$645.6K
DM 2023-03-03 2023-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +4,568 18.7K +32% $0
D 2023-03-03 2023-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +7,786 7,786 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-02 F D 1,084 $468.78 17,641 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2023-03-01 A A 2,026 $0.00 16,183 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 675 shares each on 3/1/2024 and 3/1/2025 and 676 shares on 3/1/2026.
3 Common Common Stock 2023-03-01 F D 293 $469.03 14,157 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
4 Common Common Stock 2023-03-01 A A 2,542 $0.00 18,725 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
5 Derivative Employee Stock Option (Right to Buy) 2023-03-01 A A 7,786 $0.00 7,786 D $469.03 · — to 2033-03-01 7,786 Common Stock (F4) The option represents a right to purchase a total of 7,786 shares, and is exercisable in two installments of 2,595 shares each and one installment of 2,596 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.